Narayana Health says not planning to make offer for Spire Healthcare.


Spire Healthcare shares had pared earlier strong gains by Friday afternoon after India’s Narayana Health said it does not intend to make an offer for the company.

Spire Healthcare

Source: Sharecast

Narayana made the statement in response to a story earlier in the Economic Times, which cited people familiar with the matter as saying that Narayana was in talks with Spire's shareholders about buying a controlling stake.

The Economic Times said Narayana was planning to buy at least 51% of Spire via an open offer. It also said that if Narayana managed to buy around 75%, it would consider taking the company private.

Narayana said: "We hereby clarify that the company evaluates and explores various strategic opportunities on an ongoing basis in healthcare sector for growth of its business and investment opportunities.

"At this point in time, there is no material information or event that require disclosure under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 or any other applicable law."

It said the company will make appropriate disclosure in compliance with SEBI regulations "as and when such requirement arises".

At 1250 GMT, Spire shares were up 2% at 224.00p, having traded as high as 242.61p earlier.


Exchange: London Stock Exchange
Sell:
222.00 p
Buy:
229.00 p
Change: 1.50 ( 0.67 %)
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.